リンパ血管侵入 (LVI) 胃食道交差点 (AEG) の腺がんにおける全身免疫炎症指数 (SII) と相関する: 予後分層化の影響
Gerd Jomrich1, Winny Yan1, Dagmar Kollmann1
1Department of General Surgery, Gastroesophageal Tumor Unit-Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
Cancers
|August 28, 2025
まとめ
この研究では,SII (全身免疫炎症値) とLVI (リンパ血管侵入) を組み合わせることで,特に初期手術を受けた患者の胃食道結節腺癌の予後を改善することが判明しました.
科学分野:
- 腫瘍学
- 手術腫瘍学
- 胃腸がんの研究
背景:
- 胃食道結節腺がん (AEG) は,発症率が増加し,生存率が低い攻撃的な悪性腫瘍です.
- AEGの現在のマルチモダル治療には 信頼性の高い術前予後マーカーが欠けている.
- AEGにおけるパーソナライズされた治療とフォローアップ計画において,正確な予後分層化は極めて重要です.
研究 の 目的:
- AEG患者における全身免疫炎症値 (SII) とリンパ血管侵入 (LVI) の関連性を評価する.
- AEGにおける全生存期に対するSIIとLVIの併用予後値を評価する.
- SIIとLVIの予後マーカーとしての有用性を,特に治療戦略 (前置手術とネオアジュヴァント療法) に関して決定する.
主な方法:
- 将来的に維持される機関データベースの遡及分析.
- AEGのために治療的切除を受けた患者211人を含む.
- SIIとLVIの関連性と予測値の評価
主要な成果:
- リンパ系侵入 (LVI) は患者の45%に存在し,SII値が著しく高かった.
- 高いSIIとLVIの両方が,独立してより悪い全生存率 (p < 0. 001) と関連していた.
- 初期手術を受けた患者では,高いSIIとLVIの組み合わせにより,特に予後が悪いサブグループが特定されました.
- 新補助療法を受けた患者では,SIIは強い予後因子であり続けたが,LVIの有意性は減少した.
結論:
- SIIとLVIの併用評価は,AEGにおける予後分層化を高め,特に初期手術を受ける患者にとって有益である.
- これらのマーカーは,AEG患者の個別化された治療とフォローアップ計画に役立ちます.
- AEGにおけるSIIとLVIの組み合わせを調査した最初の研究です.
さらに関連する動画
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.2K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
193
関連する概念動画
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:30Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375